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aortic stenosis who underwent TAVI in our institution between 2012
and 2014 with available pre-procedural MSCT were included. For
adjudication of the leaﬂet phenotype, diastolic (70%) and systolic
(30%) reconstructions were used. Genuine BAV was diagnosed ac-
cording to Sievers et al. (type 0: purely bileaﬂet; type 1: triﬂeaﬂet
anlage, 1 raphe; type 2: trileaftlet anlage, 2 raphes). Functional BAV
was deﬁned as tricuspid conﬁguration with symmetric geometry of all
three cusps and commissures in diastole – assuming a trileaftlet an-
lage – and bicuspid conﬁguration during systole unmasking a fusion of
two adjacent cusps. Device success according to VARC II criteria was
compared between BAV and non-BAV patients.
RESULTS Mean age was 82.2 5.9 years, logistic Euro score was 24.3 
12.2%, and 54.2% were female. With echocardiography only 15 (2.1%)
cases were classiﬁed as BAV, whereas MSCT revealed a congenital
BAV in 40 (5.8 %) cases (type 0, 1, and 2 in 7.5%, 77.5%, and 20%
respectively). A trileaﬂet anlage with functional bicuspid anatomy
was present in 13 (1.9%) patients. The overall incidence of functional
and genuine BAV was much higher than diagnosed with pre-proce-
dural echocardiography (p ¼ 0.001).
In patients with BAV, the combined endpoint of device success
according to VARC 2 was non-signiﬁcantly lower than in those with
tri-leaﬂet aortic valves (90.8% vs. 83.0%; p ¼ 0.07). However, the rate
of device-related procedural complications including device malpo-
sitioning, embolization and/or valve-in-valve implantation, was
signiﬁcantly higher in the BAV-group (11.3% vs. 3.2%; p ¼ 0.01).
CONCLUSION MSCT facilitates the identiﬁcation and classiﬁcation of
genuine or functional BAV in TAVI patients. Given a higher rate of
procedural failures, a more attentive appreciation of a bicuspid
phenotype should be encouraged.
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BACKGROUND Rheumatic Mitral valve stenosis still is an important
cause of mortality and morbidity in certain parts of the world. Mostly
the morbidity is manifested through pulmonary function limitations
causing shortness of breath and poor tolerance to physical demands.
These in turn is caused by chronic pulmonary circulatory changes
from accumulation of water, proteins and proteoglycans in pulmonary
interstitium. The degree of pulmonary involvement is directly man-
ifested by the changes of pulmonary function test (PFT) and repair of
mitral valve pathology shows signiﬁcant improvement in PFT pa-
rameters as well as in symptoms. Percutaneous Transvenous Mitral
Commissurotomy (PTMC) is an option to repair pure mitral stenosis
with relatively less risk and economic burden.
METHODS A prospective study involving 58 patients of mitral steno-
sis having New York Heart Association (NYHA) II-IV class symptoms
was done. Patients with favorable valve morphology (Wilkin’s
score<10) were selected for PTMC. Echocardiographic evaluation and
PFT were done before and 7 days after PTMC and compared using
paired student’s T test and correlation between variables were
established with Pearson’s correlation analysis.
RESULTS Two patients died from procedural complication. Others
showed signiﬁcant improvement in symptoms and hemodynamic
measurements after successful PTMC.
Before PTMC, 19 patients (33.9%) were in NYHA class III, 36 patients
(64.3%) were in class II. After PTMC, majorities (37 patients, 66.1%)
were switched over to NYHA class I and remaining 18 patients (32.1%)
were in class II. Pulmonary artery systolic pressure did not show any
correlation with forced vital capacity.Echocardiographic
ParameterGroupp valueBefore PTMC After PTMCMitral valve area
(square cm)0.764  0.1257 1.404  0.1194 <0.001Transmitral peak
pressure gradient
(mmHg)26.43  5.62 11.36  2.4000 <0.001Left atrial diameter
(mm)47.23  5.350 40.18  5.557 <0.001Pulmonary artery
systolic pressure
(mmHg)57.73  17.03 31.27 8.30 <0.001Pulmonary function
test ﬁndingsFEV1 (% of predicted
value)60.18  13.054 78.32  11.874 <0.001FVC (% of predicted
value)53.80  12.313 68.57  11.662 <0.001FEV1/FVC 112.64  16.292 114.98  12.714 0.33
PEF (L/min) 223.75  62.3215 372.05  62.200 <0.001CONCLUSION Patients with severe mitral stenosis have impaired
pulmonary function which is of restrictive type. Symptom often does
not correlate with the severity of the disease. Successful PTMC im-
proves pulmonary function, as well as, clinical status. PTMC should be
done in suitable cases to reduce morbidity in mitral stenosis. Also,
assessment of lung function in patients with mitral stenosis may aid
in timely decision-making before adopting the interventional strategy
of treatment.
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BACKGROUND Rheumatic fever and rheumatic heart disease
continue to be the major health problem in all developing countries
including Bangladesh. Percutaneous Transvenous mitral Commissur-
otomy (PTMC) is an established non-surgical modality for the treat-
ment of severe rheumatic mitral valve stenosis. The purpose of this
study was to evaluate our immediate and in-hospital results of
Percutaneous Transvenous Mitral Commissurotomy (PTMC) in pa-
tients with restenosis with previous mitral surgery (CMC).
METHODS The study group included 880 consecutive patients who
underwent PTMC at the National Institute of cardiovascular Diseases
(NICVD), Dhaka and Al –Helal Heart Institute, Mirpur, Euro-Bangla
Heart Hospital, Lalmatia, Dhaka between May 2003 and December
2012. Safety, efﬁcacy and in-hospital results of percutaneous trans-
venous mitral commissurotomy were analyzed in 800 patients un-
derwent PTMC without previous CMC (group 1) and compared with 60
those of with previous CMC (group 2).
RESULTS Baseline demographic and clinical characteristics were
similar in the 800 patients without previous CMC (group-1) and the 80
patients with previous CMC (group-2) during the procedure. In the
whole study group mitral valve area (MVA) was 0.85  0.09 cm2 prior
to PTMC, and increased to 1.76  0.07 cm2 after the procedure (p ¼
0.0001). The mean increase in MVA was 0.78  0.31 cm2 in the group-1
and 0.79  0.41 cm2 in the group-2 (NS). During the procedure or in-
hospital after PTMC, embolic events were recorded in 3 patients in
group-1 and 2 patients ingroup-2 (NS). The frequency of minor he-
matoma at puncture site in 15 patients in group-1 vs. 13 patients in
group-2 and the development of pericardial tamponade and urgent
pericardiocentesis in 3 patients ingroup-1 vs. 3 patients in group-2
were similar in both groups.
CONCLUSION PTMC in selected patients with mitral restenosis after
previous surgical commissurotomy (CMC) can be performed safely
and with similar immediate efﬁcacy and in-hospital outcome in pa-
tients with Mitral stenosis.
